Experts offered perspectives on how symptoms of rheumatic disease, such as fatigue, affect the physical, cognitive and emotional health of patients and offered solutions.
ACR Honors Distinguished Fellows: Class of 2024
At ACR Convergence 2024, the ACR honored clinical and research fellows in programs from New York to California and points between.
The 2024 ACR Awards of Distinction
The 2024 ACR Awards of Distinction honor members for their outstanding contributions to the field of rheumatology.
Environmental Threats in Rheumatic Disease
Rheumatic diseases are intrinsically linked to environmental conditions. With a constantly changing environment, how can rheumatologists adapt to the challenges of global climate change, pollution and other environmental threats? The Environment + Genetics Tamiko Katsumoto, MD, a clinical associate professor in the Division of Immunology and Rheumatology at Stanford University, Palo Alto, Calif., emphasizes the…
Tackling the Rheumatology Workforce Shortage
WASHINGTON, D.C.—The workforce shortage in rheumatology is a looming crisis that demands immediate attention. The ACR’s 2015 Workforce Study projected that by 2030, the supply of adult rheumatologists would dwindle by 31%, in contrast to the increase in demand by close to 138%.1 The situation is even worse for pediatric rheumatology and in rural and…
The Management of Psoriatic Arthritis: A Review
WASHINGTON, D.C.—As of November 2024, there are 16 biologic disease-modifying anti-rheumatic drugs (bDMARDs) that are FDA approved for the treatment of psoriatic arthritis (PsA). Incredible news, right? But as my fellowship program director used to say, “There’s no free lunch.” This buffet of options is excellent for our patients, but poses challenges to the practicing…
Young Adults with Psoriatic Disease at Risk of Early Cardiovascular Disease
Background/Purpose Psoriasis and psoriatic arthritis (PsA) are closely linked inflammatory conditions that can affect both children and adults. In children, these diseases are associated with traditional cardiovascular disease risk factors and subclinical atherosclerosis. In older adults, systemic inflammation from psoriasis and PsA accelerates atherosclerosis, and these conditions are independent risk factors for severe cardiovascular disease…
Annual RheumPAC Matching Campaign & Donor Appreciation Event
There’s still time to contribute and attend RheumPAC’s event at ACR Convergence 2024. If you haven’t yet made your 2024 donation, this is the best time to do so—thanks to generous champions, every contribution will be amplified.
Meet the Professor: Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a complex, immune-mediated inflammatory disorder characterized by inflammatory back pain and axial arthritis. Typical of other diseases in the spondyloarthritis family, the clinical phenotypes can be diverse, and an array of comorbidities often accompanies the spinal disease. “In this Meet the Professor Session at ACR Convergence 2024,” says Christopher Ritchlin, MD,…
ACR Convergence Sessions on AI, APPs Can Boost Practice Efficiency
Sessions on the use of AI to aid documentation and on hiring advanced practice providers could help your rheumatology practice save time and money.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 36
- Next Page »